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RKIP was ﬁrst identiﬁed as an inhibitor of the Raf-MEK-ERK signaling pathway. RKIP was also found
to play an important role in the NF-jB pathway. Genetic and biochemical studies demonstrated that
RKIP functioned as a scaffold protein facilitating the phosphorylation of IjB by upstream kinases.
However, contrary to what one would expect of a scaffold protein, our results show that RKIP has
an overall inhibitory effect on the NF-jB transcriptional activities. Since NF-jB target gene expres-
sion is subject to negative regulation involving the optimal induction of negative regulators, our
data support a hypothesis that RKIP inhibits NF-jB activity via the auto-regulatory feedback loop
by rapidly inducing the expression and synthesis of inhibitors of NF-jB activation.
Structured summary:
MINT-7386121: TRAF6 (uniprotkb:Q9Y4K3) physically interacts (MI:0915) with RKIP (uniprotkb:P30086)
by anti bait co-immunoprecipitation (MI:0006)
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
NF-jB is a transcriptional activator that is required for the up-
regulation of a large number of genes encoding proteins that are
important for immunity, cell proliferation and survival [1,2]. NF-
jB consists of homo- and hetero-dimeric complexes of the REL
family polypeptides. In the absence of stimulating signals, the
NF-jB dimeric complex is retained in the cytoplasm in an inactive
form bound to IjB. In response to stimulatory signals IjB is rapidly
phosphorylated by the IKK complex, which contains two kinase
subunits, IKKa and IKKb and a regulatory subunit called IKKc/
NEMO. The phosphorylated IjB will subsequently be ubiquitinated
and degraded releasing the NF-jB dimer for nuclear import [3].
One of the potent activators of the NF-jB is the pro-inﬂamma-
tory cytokine IL1-b [4]. Genetic studies have further shown that
TAK1 is the critical direct upstream activating kinase of IKK [5].
The activation of NF-jB in response to stimulation by IL1-b has
been extensively studied, however, the mechanisms that modulate
and eventually limit these responses are still poorly understood.
RKIP was ﬁrst identiﬁed as an interacting partner of Raf-1, and
shown to function as a negative regulator of the MAPK cascade ini-
tiated by Raf-1 [7]. The Raf-1 initiated pathway is comprised of
three sequentially acting protein kinases: a MAPK kinase kinasechemical Societies. Published by E
ng).(MAPKKK), a MAPK kinase (MAPKK), and a MAPK; this basic rela-
tionship has now been found to be conserved in several protein ki-
nase pathways including the one required for the phosphorylation
of IjB. In the Raf-1 pathway the MAPK is ERK1/2, the MAPKK is
MEK1/2, and the MAPKKK is Raf-1 itself. Functional studies using
both gain-of-function and loss-of-function approaches demon-
strated that RKIP disrupts the interaction between Raf-1 and
MEK1/2 resulting in a downregulation of MEK1/2 activation phos-
phorylation [6]. Previously we showed that RKIP interacted with
TAK1 and IKKa/b of the NF-jB core kinase cascade. Here we show
that RKIP also interacts with TRAF6, the upstream activator of IKK
kinase complex. The interaction is ligand-dependent and precedes
the degradation of IjB. We show that the effect of RKIP was
concentration-dependent. The presence of RKIP favored the
optimal ubiquitination of IRAK, TRAF6, and TAK1 as well as the
assembly of the IKK complex. We show that RKIP facilitated
the phosphorylation of IjB by IKKs. Our results therefore are
consistent with the notion that RKIP is a scaffold protein of the
IKK complex.
2. Methods
2.1. Cell cultures
Cos-1, and 293mycIL1R cells were grown in Dulbecco’s modi-
ﬁed Eagle’s medium (DMEM) supplemented with 10% fetal bovinelsevier B.V. All rights reserved.
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Ham’12 medium supplemented with 10% fetal bovine serum, 1%
penicillin/streptomycin, and 0.15% NaHCO3.
2.2. Antibodies
Antibodies to p-IkBa were purchased from Upstate Biotechnol-
ogy. Antibodies to ERK, p-ERK, p38, p-p38, JNK, p-JNK, IjBa, p65,
IKKa, and phospho-IKKa were purchased from Cell Signaling.
Anti-HA peroxidase was purchased from Roche. 12CA5 and 9E10
antibodies were puriﬁed from hybridoma supernatants with pro-
tein G-Agarose (Upstate).
2.3. Real time PCR and PCR array analysis
Total cellular RNA was extracted with the Trizol reagent (Invit-
rogen) and reverse transcribed using random hexamer primers
(Applied Biosystems). The resulting cDNAs were used for PCR using
SYBR-Green Master PCR mix (Applied Biosystems) in triplicates.
PCR and data collection were performed on ABI7500 (Applied Bio-
systems). b-Actin were used as an internal standard.
A detailed description of materials and methods is given in Sup-
plementary data.3. Results and discussion
3.1. Both ectopic expression and knockdown of RKIP expression
impairs the phosphorylation of IjBa in response to IL1-b stimulation
Previously we showed that over expression of RKIP inhibited
IjB degradation following treatment with pro-inﬂammatory cyto-
kines [8]. Mechanistically RKIP may impair by either inhibiting the
phosphorylation of IjB by IKK or acting after the phosphorylation
of IjB. To evaluate these alternative possibilities, we examined the
effect of RKIP on IjB phosphorylation in DU145 cells treated with
proteasome inhibitor ALLN. The prostate cancer cells DU145 have
an elevated level of IKK activity and IjB is continuously being
phosphorylated and degraded. In the presence of ALLN phosphory-
lated IjB is stabilized and will not be degraded. We monitored di-
rectly the effect of RKIP on the phosphorylation of IjBa at Ser32/36
by phosphospeciﬁc Ab. Ectopic expression of RKIP reduced the
amount of phospho-IjB without affecting the expression levels of
IjB (Fig. 1a). Our results therefore show that ectopic expression
of RKIP inhibits the activation of NF-jB at least partly by prevent-
ing the phosphorylation of IjB.
We reasoned that if RKIP is a repressor of IjB degradation we
should expect an opposite effect when RKIP is inactivated. Unex-
pectedly, we observed the same effect when the expression of RKIP
was down regulated by speciﬁc siRNA. We observed changes both
in the kinetics and magnitude of the IjB degradation in RKIP
knockdown cells (Fig. 1b). To evaluate the effect of RKIP knock-
down on IjB phosphorylation we constructed an IjB variant
IjBKR, which contained mutations in two of its major ubiquitina-
tion sites and hence could be phosphorylated but not degraded.
Consistent with results with ectopic RKIP expression we observed
that the effect of RKIP knockdown was also at the level of IjB phos-
phorylation (Fig. 1c). Our results therefore suggest that RKIP facil-
itates the IjB phosphorylation/degradation upon IL1-b
stimulation. The effect of RKIP on the NF-jB signaling is speciﬁc,
as knocking down of RKIP expression has little effect on the IL1-
b-mediated phosphorylation activation of p38 and JNK (Fig. 1d).
The effect of the siRNA was speciﬁc, as the control siRNA (siLUC)
had no effect on the IL1-b-induced IjB degradation when
compared with normal cell control (data not shown). Furthermore
the effect of RKIP siRNA could be reversed by expression of aversion of RKIP gene that was not recognized by the RKIP speciﬁc
siRNA (Fig. 1e). To ensure the effect is not cell type speciﬁc we also
examined the effect of RKIP expression in human lung epithelial
cells A549 that are highly responsive to IL1b stimulation. We ob-
served a similar effect of RKIP on IL1-b-mediated IjB degrada-
tion/phosphorylation in A541 cells (Fig. 1f).3.2. RKIP functions as a scaffold in NF-jB pathway
Since both RKIP gain-of-function and loss-of-function have the
same effect on the phosphorylation of IjB, our results therefore
raise the possibility that RKIP may function as a scaffold protein.
Several essential attributes of a scaffold protein have been de-
scribed. A scaffold protein has the ability to interact with many
components of the signaling pathway and thereby facilitates the
assembly of a multi-component protein complex. The function of
a scaffold protein is concentration-dependent.
We have previously shown that RKIP associates with NIK, IKKa/
b, and TAK1 of the NF-jB pathways [8]. To investigate whether
RKIP also interacts with upstream activators of the IKK complex
we studied the interaction of RKIP with TRAF6 by co-immunopre-
cipitation. We observed that RKIP interacted with TRAF6 when
overexpressed (Fig. 2a). The association is physiologically relevant
as the endogenous RKIP was also found associated with TRAF6 and
the association was ligand-dependent (Fig. 2b). The interaction
with TRAF6 was speciﬁc, as no detectable RKIP was found in co-
immunoprecipitates when other closely related TRAFs (TRAF1, 2,
3, and TRAF5) or IRAK were used (Fig. 2a and data not shown). It
has been shown previously that the association of TRAF6 with
IRAK, TAK1, and IKK is essential for the IL1-b-induced phosphory-
lation and degradation of IjB. Consistent with the notion that RKIP
is a scaffold protein, the association of TRAF6 with IRAK, IKKb or
TAK1 is greatly reduced in the absence of RKIP (Fig. 2c and d).
Next we examined whether RKIP exists as a single complex
with components of the NF-jB pathway. We began by examining
whether RKIP interacts with TAK1 and TRAF6 simultaneously by
co-immunoprecipitation after the proteins were crosslinked
in vivo by DTBP. Consistent with the notion that RKIP, TAK1, and
TRAF6 coexist in the same complex we detected RKIP and TAK1
in complexes immunoprecipitated by Abs that recognized TRAF6
(Fig. 2e). To ensure that the whole complex but not individual
sub-complexes were co-immunoprecipitated, the complexes were
eluted from the 1st Ab and immunoprecipitated with an Ab that
recognized another component in the complex, TAK1. The results
are shown in (Fig. 2e, right panel).
Lastly we examined whether the effect of RKIP on NF-jB signal-
ing pathway is concentration-dependent. We co-transfected
293IL1R RKIP knockdown cells with ﬂag-tagged IjB and different
amounts of RKIP and monitored the degradation of the IjB byWes-
tern blotting. With expected function as a scaffold protein, RKIP
exhibited a biphasic effect on the IL1-b mediated degradation of
IjB (Fig. 2f).3.3. Down regulation of RKIP decreases the ubiquitination of IRAK,
TRAF6, and TAK1
The activation of IKK results from a sequential ubiquitination
and phosphorylation of several upstream modulators and kinases
including IRAK, the E3 ubiquitin ligase TRAF6 and TAK1. Conceptu-
ally RKIP loss-of-function may directly affect the phosphorylation
of IjB by IKK. Alternatively, the effect of RKIP loss-of-function
mutation may be upstream of IKK. To evaluate these alternative
possibilities, we examined the effect of RKIP knockdown on the
phosphorylation and/or ubiquitination of IRAK, TRAF6, TAK1, and
IKK.
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Fig. 1. (a) DU145 cells were infected with the indicated expression plasmid DNAs. Transfected cells were treated with ALLN or carrier control for 3 h before harvesting for
immunoblotting with speciﬁc Abs as indicated. (b) Serum starved RKIP or control knockdown 293ILR cells were stimulated with IL1-b. Lysates were immunoblotted with the
indicated speciﬁc antibodies. Relative levels of IjB/tubulin are indicated. (c) Same as (b), except the cells were transfected with ﬂag-tagged IjB (f-IjBKR). (d) 293ILR cells
were stimulated and analyzed as described in (b). (e) Same as (b), except the cells were transfected with the indicated expression plasmid DNAs. (f) Serum starved RKIP or
control knockdown A549 cells were stimulated and analyzed as described in (b). The experiments were repeated at least three times with similar results.
664 H. Tang et al. / FEBS Letters 584 (2010) 662–668In agreement with the effect of RKIP knockdown on IjB phos-
phorylation and degradation, we observed decreases in IRAK,
TRAF6, and TAK1 ubiquitination as well as phosphorylation of
TAK1 and IKK kinases (Fig. 3a–c). As expected from decreases in
the activation of the upstream activators of IjB phosphorylation
and degradation, we also observed reduced nuclear translocation
of the p65 and p50 subunits of the NF-jB and its subsequent bind-
ing to promoters of target genes (Fig. 3d and e). In short our data
suggest that RKIP is a scaffold protein that facilitates the assembly
of the IKK complex leading to the degradation of IjB releasing the
NF-jB for nuclear translocation (see Fig. 3f for summary).
3.4. Down regulation of RKIP increases the basal expression of a
selected group of NF-jB target genes
To investigate the biological consequences of the scaffold func-
tion of RKIP in the NF-jB pathway we decided to monitor the
expression proﬁle of a representative group of inﬂammatory cyto-
kines and receptors genes by quantitative RT-PCR array analysis.
We focused on 84 key genes of chemokines, cytokines, and inter-
leukins as well as their receptors. This group of genes was chosen
because it contained veriﬁed targets of the NF-jB pathway initi-
ated by the pro-inﬂammatory cytokine IL1-b. Normalized mRNA
levels ranging from 300 to 2 relative to the non-stimulated
control were observed in A549 control or RKIP knockdown cells
after stimulation for 6 h with IL1-b. As expected a group ofNF-jB regulated genes including CXCL1-3, CXCL5, CXCL10-11,
CCL2, CCL4-5, CCL20, IL8, TNFa, and LTb were highly activated
(10–300-fold) (Fig. 4a, the last six columns) when cells were
stimulated with IL1-b for 6 h. Unexpectedly, the expression of this
same group of genes was also elevated in quiescent RKIP knock-
down cells when compared with the control GFP knockdown
A549 cells (Fig. 4a, ﬁrst two columns). Consequently the differ-
ences in the overall increase in IL1-b stimulated gene expression
due to the speciﬁc RKIP knockdown are insigniﬁcant. Although
NF-jB is essential for the expression of this group of genes, other
signaling pathways including JNK, ERK, and p38 are also involved.
To ensure the effect of RKIP is NF-jB speciﬁc we examined the
expression an artiﬁcial NF-jB reporter in A549 cells when RKIP
expression was knocked down by speciﬁc siRNA. Consistent with
the quantitative RT-PCR arrays analysis results, we also observed
elevated activities of an artiﬁcial NF-jB reporter in quiescent
A549 cells when RKIP expression was knocked down by speciﬁc
siRNA and these activities were further induced after IL1-b stimu-
lation (Fig. 4b).
3.5. RKIP is required for the auto-regulation of NF-jB targeted genes
expression
Previously we showed that neutralization of RKIP by Ab in-
creased NF-jB responsive reporter activities in quiescent cells
[9]. Consistent with our previous results, here we show that
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H. Tang et al. / FEBS Letters 584 (2010) 662–668 665downregulation of RKIP expression by siRNA increases the basal
expression of NF-jB target genes (Fig. 4a and b). Our results
therefore seem at odds with the observation that the signaling
leading to degradation of the IjB was reduced in knockdown
cells. However, since the regulation of NF-jB target genes expres-
sion is subjected to negative regulation involving the optimal
induction of negative regulators, our results could result from
the impairment of the negative feedback loop imposed by the
induction of negative regulators. Indeed we observed a decrease
in IjB gene expression in RKIP knockdown A549 cells at earlier
times after stimulation with IL1-b (Fig. 4c) and reduction in the
re-synthesis of IjB protein after its degradation (Fig. 4d). Beside
IjB we also observed reductions in the expression of two other
NF-jB target genes, A20 and cyld, that encode negative regulators
of the NF-jB pathway (Fig. 4e). Our data therefore are consistent
with the model that RKIP inhibits the NF-jB pathway by enhanc-
ing the negative regulatory loop.
Here we show that RKIP interacts with multiple components of
the IL1-b stimulated NF-jB pathway. Both overexpression anddownregulation of RKIP expression impaired the degradation of
IjB upon IL1-b stimulation. Studies of IKK/TAK1 activating phos-
phorylation, and IRAK/TRAF6/TAK1 ubiquitination suggested that
RKIP acted downstream of or parallel to IRAK and upstream of
IjB. Downregulation of RKIP decreased the phosphorylation of
IjB, IKKa/b, and TAK1 and diminished the ubiquitination of
TAK1, TRAF6, and IRAK. Our results therefore suggest that RKIP
functions as a scaffold protein facilitating the activation of IKK
complex by the E3 ubiquitinase TRAF6. Scaffold proteins can bind
concurrently with several signaling molecules in the kinase
cascade. We showed that RKIP associated with TRAF6, TAK1, or
IKKa/b. Although we also demonstrated that RKIP existed in a ter-
nary complex with TRAF6, and TAK1, it remains to be determined
whether RKIP also can bind simultaneously with the rest of the IKK
complex. It will also be of interest to determine regions in RKIP
that interact with different components of the NF-jB pathway.
The involvement of scaffolding proteins in signal transduction is
evolutionarily conserved. The functions of scaffold proteins in sig-
naling pathways requiring MAPKs are well studied [10–14]. On the
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666 H. Tang et al. / FEBS Letters 584 (2010) 662–668contrary, a scaffold protein that is directly involved in the IjB
phosphorylation by upstream kinases has not been conclusively
demonstrated. Hence, RKIP is the ﬁrst example of a scaffold protein
that directly stimulates the association of the IKK complex with the
TRAF6 E3 ligase. RKIP is a member of the PEBP protein family. Re-
cently it was shown that another PEBP family member, PEBP4, was
a scaffolding protein of the Raf-MEK-ERK signaling pathway [15].
Unlike PEBP4, we have previously demonstrated that RKIP does
not function as a scaffold in the Raf-MEK-ERK pathway but func-
tions as a competitive inhibitor of the activation phosphorylation
of MEK by Raf1 [6]. Our results therefore showed that RKIP em-
ploys different mechanisms to regulate different signaling path-
ways. The effect of PEBP4 on NF-jB pathway is currently unknown.
RKIP is a small protein with one identiﬁed ligand-binding pock-
et. How can this small protein bind concurrently with multiple
proteins? One possibility is that additional protein(s) may be in-
volved. It is possible that the scaffolding function of RKIP requiresthe presence of a novel RKIP yet-to-be-identiﬁed interacting pro-
tein. Together they provide a platform for other components of
NF-jB pathway to interact. One precedent example of such a scaf-
fold complex is the MP1/p14 complex [16,17].
In agreement with our earlier knockdown study with RKIP neu-
tralization Ab, we observed an overall stimulatory effect on the ba-
sal transcription activities of NF-jB target genes by reporter assay
and PCR array analysis. Increase in NF-jB transcriptional activities
in spite of a decrease in IjB degradation is largely unexpected.
Studies on expression of NF-jB target genes raise the possibility
that the inhibitory effect of RKIP results from increased transcrip-
tion of negative regulators of NF-jB signaling. In fact we observed
a decrease in the expression of NF-jB early gene targets that en-
code negative regulators as IjB, A20, and Cyld in IL1-b stimulated
RKIP knockdown A549 cells. Future work involving global monitor-
ing of NF-jB target genes expression kinetics is required to further
investigate this possibility.
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H. Tang et al. / FEBS Letters 584 (2010) 662–668 667RKIP was ﬁrst identiﬁed as an endogenous negative regulator of
the Raf/MEK/ERK signaling pathway [7]. Here we show that RKIP
acts like a scaffold facilitating the phosphorylation of IjB by up-
stream kinases. The kinetics of RKIP interaction with NF-jB path-
way components also differs signiﬁcantly from its interaction
with Raf-1. While RKIP associates with Raf-1 in quiescent cells,
the association of RKIP with TRAF6 or TAK1 is IL1-b-dependent.
Therefore, depending on how RKIP interacts with its targets, dispa-
rate mechanisms are used by RKIP to control different signaling
pathways. Our studies therefore suggest that RKIP represents a no-
vel regulator of multiple signal transduction pathways.
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